Bernd P
Dev Biol. 1986 Jun;115(2):415-24. doi: 10.1016/0012-1606(86)90261-7.
Cultured neural crest cells undergoing differentiation have been shown to contain a subpopulation of cells with specific receptors for nerve growth factor (NGF). These cells are the potential targets of NGF during differentiation and development. This study was done to pharmacologically characterize the binding of NGF to long-term (1- to 3-week) cultures of quail neural crest cells. The data indicate that 125I-NGF binding was specific and saturable, with less than 20% nonspecific binding. Scatchard analysis revealed the presence of one type (class) of receptors with a binding constant (Kd) similar to that of the low-affinity binding site described for embryonic dorsal root and sympathetic ganglia (approximately 3.2 nM). This was corroborated by displacement experiments (Kd of 1.3 nM), in which 125I-NGF binding was measured in the presence of increasing concentrations of nonradioactive NGF. In addition, affinity labeling revealed that the 125I-NGF-receptor complex had a molecular weight of about 93K, characteristic of the low-affinity NGF receptor of PC12 cells. The NGF receptor of cultured neural crest cells was trypsin-sensitive, as is typical of the low-affinity NGF binding sites. These findings indicate that differentiating neural crest cells lack high-affinity 125I-NGF binding sites. In contrast, embryonic dorsal root and sympathetic ganglia cells, known NGF targets, have both high- and low-affinity receptors. Measurements of the differential release of surface-bound 125I-NGF indicated that a relatively small amount (about 14%) of NGF is internalized over a 1-hr period. Cultured neural crest cells which bear NGF receptors were also shown by light microscopic radioautographic techniques to incorporate [3H]thymidine. I suggest, therefore, that cultured neural crest cells which have not terminally differentiated, as judged by morphological criteria and continued proliferation, may express an early developmental form of the NGF receptor.
已显示正在分化的培养神经嵴细胞含有具有神经生长因子(NGF)特异性受体的细胞亚群。这些细胞是分化和发育过程中NGF的潜在靶标。本研究旨在从药理学角度表征NGF与鹌鹑神经嵴细胞长期(1至3周)培养物的结合。数据表明,125I-NGF结合是特异性的且可饱和的,非特异性结合少于20%。Scatchard分析显示存在一种类型(类别)的受体,其结合常数(Kd)与胚胎背根和交感神经节中描述的低亲和力结合位点相似(约3.2 nM)。这在置换实验(Kd为1.3 nM)中得到了证实,在该实验中,在存在浓度不断增加的非放射性NGF的情况下测量125I-NGF结合。此外,亲和标记显示125I-NGF-受体复合物的分子量约为93K,这是PC12细胞低亲和力NGF受体的特征。培养的神经嵴细胞的NGF受体对胰蛋白酶敏感,这是低亲和力NGF结合位点的典型特征。这些发现表明,正在分化的神经嵴细胞缺乏高亲和力的125I-NGF结合位点。相比之下,已知的NGF靶标胚胎背根和交感神经节细胞同时具有高亲和力和低亲和力受体。表面结合的125I-NGF的差异释放测量表明,在1小时内相对少量(约14%)的NGF被内化。通过光学显微镜放射自显影技术还显示,带有NGF受体的培养神经嵴细胞掺入了[3H]胸腺嘧啶核苷。因此,我认为,根据形态学标准和持续增殖判断尚未终末分化的培养神经嵴细胞可能表达NGF受体的早期发育形式。